Wet AMD 5 Symposium

Related

• 

  FIDO Study: 10-Year Outcomes of Eyes Receiving Continuous, Fixed-Interval Dosing of Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration

  Ivan J. Suner, MD, MBA

  Annual Meeting Talks

  2019

• 

  Episode 4: 3-year Results of the TREX-AMD Trial with Dr. Charles Wykoff

  Keyvan Koushan, MD, FRCSC

  Member Podcasts

  2017

• 

  Prognostic Value of Subretinal Hyperreflective Material

  Russell Pokroy, MD

  Updates from the Field

  2017